Advisor Group Holdings, Inc. Astrazeneca PLC Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 207,871 shares of AZN stock, worth $14.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

207,871

Previous 125,689 65.39%

Holding current value

$14.1 Million

Previous $9.8 Million 65.24%

% of portfolio

0.04%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $6.3 Million - $7.2 Million	82,182 Added 65.39%	207,871 $16.2 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $3.26 Million - $3.94 Million	-48,789 Reduced 27.96%	125,689 $9.8 Million
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $9.55 Million - $10.9 Million	-156,475 Reduced 47.28%	174,478 $11.8 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $151,939 - $170,082	-2,455 Reduced 0.74%	330,953 $22.3 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $5.68 Million - $6.28 Million	87,648 Added 35.66%	333,408 $22.6 Million
Q2 2023 Aug 21, 2023	SELL	$69.91 - $75.81 $1.61 Million - $1.74 Million	-23,006 Reduced 8.56%	245,760 $17.6 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $234,338 - $254,115	-3,352 Reduced 1.23%	268,766 $19.2 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $3.04 Million - $3.44 Million	48,068 Added 21.45%	272,118 $18.9 Million
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $1.21 Million - $1.58 Million	22,395 Added 11.11%	224,050 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1.01 Million - $2.6 Million	19,119 Added 10.47%	201,655 $11.1 Million
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $925,167 - $1.11 Million	-15,612 Reduced 7.88%	182,536 $12.1 Million
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $1.12 Million - $1.35 Million	20,170 Added 11.33%	198,148 $11.4 Million
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $1.98 Million - $2.16 Million	35,563 Added 24.97%	177,978 $10.7 Million
Q2 2021 Aug 02, 2021	BUY	$48.42 - $60.18 $685,966 - $852,570	14,167 Added 11.05%	142,415 $8.45 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $777,338 - $897,334	-16,483 Reduced 11.39%	128,248 $6.38 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $663,511 - $793,423	13,675 Added 10.43%	144,731 $7.23 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $1 Million - $1.15 Million	18,865 Added 16.82%	131,056 $7.17 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $2.2 Million - $2.82 Million	-50,997 Reduced 31.25%	112,191 $5.94 Million
Q1 2020 May 18, 2020	BUY	$37.79 - $51.33 $6.17 Million - $8.38 Million	163,188 New	163,188 $4.22 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $211B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Astrazeneca PLC Transaction History